These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18051573)

  • 1. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
    Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
    Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation and in vivo tumorigenicity assay of CD133+ side population cells from laryngeal cancer cell line].
    Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):223-7. PubMed ID: 22805024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
    Wang M; Li X; Qu Y; Xu O; Sun Q
    Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
    Wei XD; He J; Gao JX; Wang JY; Ma BJ; Chen J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):578-83. PubMed ID: 24313208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
    Yu D; Jin CS; Chen O; Wen LJ; Gao LF
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.
    Meng X; Li M; Wang X; Wang Y; Ma D
    Cancer Sci; 2009 Jun; 100(6):1040-6. PubMed ID: 19385971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of self-renewal mechanism about CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
    Wei X; He J; Gao J; Chen J; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 28(21):1636-41. PubMed ID: 25735089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
    Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
    Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
    Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoplasms stem cells play an important role in resistance of laryngeal squamous cancer to chemoradiotherapy].
    Han R; Huangfu H; Gao W; Zhang C; Jin Y; Li Z; Wang B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):400-5. PubMed ID: 24961129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
    Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
    Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How powerful is CD133 as a cancer stem cell marker in brain tumors?
    Cheng JX; Liu BL; Zhang X
    Cancer Treat Rev; 2009 Aug; 35(5):403-8. PubMed ID: 19369008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.